The US Department of Health and Human Services (HHS) issued new guidance clarifying how pharmaceutical manufacturers can ...
Public Citizen filed a lawsuit against the Trump administration in the U.S. District Court for the District of Columbia ...
In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still ...
Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...
PE: After presenting topline results from Phase 3 trials, what's next for Varegacestat? Siegall: We presented topline data.
PE: What key learnings did your team learn during launch? Skalicky: Three things come to mind. First, integration beats ...
Gavi, the Vaccine Alliance, is a group that describes itself as being focused on improving access to vaccines for children living in the world’s poorest countries. While the United States previously ...
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...
If you want the cleanest case study of pharma and diagnostics actually operating as one strategic engine, it’s Roche. Roche ...
Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...
Papzimeos, an HPV-specific immunotherapy, is the first FDA-approved treatment for recurrent respiratory papillomatosis, ...
In today’s Pharmaceutical Executive Daily, Insilico Medicine and Qilu Pharmaceuticals launch a $120 million collaboration to advance AI-driven cardiometabolic therapies, Eli Lilly enters a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results